Literature DB >> 11273006

Acute cytoskeletal alterations and cell death induced by experimental brain injury are attenuated by magnesium treatment and exacerbated by magnesium deficiency.

K E Saatman1, F M Bareyre, M S Grady, T K McIntosh.   

Abstract

Traumatic brain injury results in a profound decline in intracellular magnesium ion levels that may jeopardize critical cellular functions. We examined the consequences of preinjury magnesium deficiency and post-traumatic magnesium treatment on injury-induced cytoskeletal damage and cell death at 24 h after injury. Adult male rats were fed either a normal (n = 24) or magnesium-deficient diet (n = 16) for 2 wk prior to anesthesia and lateral fluid percussion brain injury (n = 31) or sham injury (n = 9). Normally fed animals were then randomized to receive magnesium chloride (125 micromol, i.v., n = 10) or vehicle solution (n = 11) at 10 min postinjury. Magnesium treatment reduced cortical cell loss (p < 0.05), cortical alterations in microtubule-associated protein-2 (MAP-2) (p < 0.05), and both cortical and hippocampal calpain-mediated spectrin breakdown (p < 0.05 for each region) when compared to vehicle treatment. Conversely, magnesium deficiency prior to brain injury led to a greater area of cortical cell loss (p < 0.05 compared to vehicle treatment). Moreover, brain injury to magnesium-deficient rats resulted in cytoskeletal alterations within the cortex and hippocampus that were not observed in vehicle- or magnesium-treated animals. These data suggest that cortical cell death and cytoskeletal disruptions in cortical and hippocampal neurons may be sensitive to magnesium status after experimental brain injury, and may be mediated in part through modulation of calpains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11273006     DOI: 10.1093/jnen/60.2.183

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  15 in total

1.  The importance of magnesium in critically ill patients: a role in mitigating neurological injury and in the prevention of vasospasms.

Authors:  Kees H Polderman; Arthur R H van Zanten; Armand R J Girbes
Journal:  Intensive Care Med       Date:  2003-05-24       Impact factor: 17.440

Review 2.  Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

3.  Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat.

Authors:  Niklas Marklund; Carl T Fulp; Saori Shimizu; Rishi Puri; Asenia McMillan; Stephen M Strittmatter; Tracy K McIntosh
Journal:  Exp Neurol       Date:  2006-01       Impact factor: 5.330

4.  Cognitive evaluation of traumatically brain-injured rats using serial testing in the Morris water maze.

Authors:  Hilaire J Thompson; David G LeBold; Niklas Marklund; Diego M Morales; Andrew P Hagner; Tracy K McIntosh
Journal:  Restor Neurol Neurosci       Date:  2006       Impact factor: 2.406

5.  When basic research doesn't translate to the bedside--lessons from the magnesium brain trauma study.

Authors:  John W Miller; Raimondo D'Ambrosio
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

6.  Mechanisms of calpain mediated proteolysis of voltage gated sodium channel α-subunits following in vitro dynamic stretch injury.

Authors:  Catherine R von Reyn; Rosalind E Mott; Robert Siman; Douglas H Smith; David F Meaney
Journal:  J Neurochem       Date:  2012-04-12       Impact factor: 5.372

Review 7.  Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

Authors:  Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt
Journal:  J Child Psychol Psychiatry       Date:  2010-02-26       Impact factor: 8.982

Review 8.  Coagulopathy in traumatic brain injury.

Authors:  Sherman C Stein; Douglas H Smith
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 9.  Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

Authors:  Niklas Marklund; Lars Hillered
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 10.  Pharmacology of traumatic brain injury: where is the "golden bullet"?

Authors:  Kathryn Beauchamp; Haitham Mutlak; Wade R Smith; Esther Shohami; Philip F Stahel
Journal:  Mol Med       Date:  2008-08-18       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.